The study of interaction of different forms of human recombinant anti-mullerian hormone with a chimeric analogue of the AMH type II

   
Rak A.Ya.1 , Trofimov A.V.1, Ischenko A.M.1, Sokolov A.V.2

1. State Research Institute for Highly Pure Biopreparations, Saint-Petersburg, Russia
2. Institute of Experimental Medicine, St. Petersburg, Russia
Section: Experimental Study
DOI: 10.18097/PBMC20216701066      PubMed Id: 33645523
Year: 2021  Volume: 67  Issue: 1  Pages: 66-73
The homodimeric glycoprotein, anti-mullerian hormone (AMH), described over 70 years ago by A. Jost, is the least studied member of the transforming growth factor beta superfamily. Despite the antitumor activity of AMH discovered at the end of the last century, the creation of effective drugs based on AMH is hindered primarily by the lack of information on the mechanism of various AMH forms interaction with a specific type II receptor (MISRII). Previously, we have shown that not only the full-length activated hormone but also its C-terminal fragment (C-rAMH) could bind to MISRII. In this work, using the surface plasmon resonance technique, we compared the interaction of three forms of recombinant AMH (rAMH) with the MISRII analogue — the chimeric protein MISRII-Fc containing AMH type II receptor and a Fc-fragment of the human IgG1 heavy chain. Comparison of the binding of MISRII-Fc, immobilized on a chip with group specificity for human immunoglobulins, to C-rAMH, to intact rAMH (pro-rAMH), and to rAMH containing one uncleaved monomer (hc-rAMH), showed that the KD of the complexes increased: 1.7 nM, 88 nM and 110 nM, respectively. Thus, we have shown that C-terminal fragment of AMH has the maximum affinity for the recombinant MISRII analogue, which indicates the prospects for the development of drugs based on this hormone derivative.
Download PDF:  
Keywords: anti-mullerian hormone, AMH type II receptor, protein-protein interaction, surface plasmon resonance, chimeric protein
Citation:

Rak, A. Ya., Trofimov, A. V., Ischenko, A. M., Sokolov, A. V. (2021). The study of interaction of different forms of human recombinant anti-mullerian hormone with a chimeric analogue of the AMH type II. Biomeditsinskaya Khimiya, 67(1), 66-73.
This paper is also available as the English translation: 10.1134/S1990750821030082
References  
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)